Old Web
English
Sign In
Acemap
>
authorDetail
>
Martin Wolfsegger
Martin Wolfsegger
Shire plc
Immunology
Medicine
Antibody
Pharmacology
Toxicity
4
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics, disease-modifying activity, and safety of an experimental therapeutic targeting an immunological isoform of macrophage migration inhibitory factor, in rat glomerulonephritis
2018
European Journal of Pharmacology
Werner Höllriegl
Alexander Bauer
Bernhard Baumgartner
Barbara Dietrich
Patrice Douillard
Randolf J. Kerschbaumer
Gerald Höbarth
Jeffrey S. McKee
Alexander Schinagl
Frederick W.K. Tam
Michael Thiele
Alfred Weber
Martin Wolfsegger
Marietta Turecek
Eva-Maria Muchitsch
Friedrich Scheiflinger
Helmut Glantschnig
Show All
Source
Cite
Save
Citations (2)
Nonclinical Assessment of Bax 604 (FEIBA STAR) - Reduced Volume Reconstitution & Higher Infusion Rate
2016
Blood
Gerald Hoebarth
Alexandra Kopic
Martin Wolfsegger
Alexander Bauer
Peter Turecek
Peter Leidenmuehler
Karima Benamara
Werner Hoellriegl
Marietta Turecek
Show All
Source
Cite
Save
Citations (0)
Modelling FVIII Levels for Prediction of Zero Spontaneous-Joint Bleeding in a Cohort of Severe Hemophilia a Subjects with Target Joints Initiated on Tertiary Prophylaxis
2016
Blood
K. Fischer
Pratima Chowdary
Peter William Collins
Amy Cotterill
Barbara A. Konkle
Victor S. Blanchette
Steven W. Pipe
Martin Wolfsegger
Werner Engl
Jimena Goldstine
Leonard A. Valentino
Gerald Spotts
Show All
Source
Cite
Save
Citations (3)
Nonclinical Safety of SHP 826 (BAX 826), a Next Generation Extended Half-Life Recombinant Factor VIII Product
2016
Blood
Veronika Ehrlich
Peter Leidenmuehler
Barbara Dietrich
Gerald Hoebarth
Tanja Ruthsatz
Peter Turecek
Martin Wolfsegger
Alfred Weber
Herbert Gritsch
Werner Hoellriegl
Marietta Turecek
Show All
Source
Cite
Save
Citations (2)
1